The interplay between host immune cells and gut microbiota in chronic inflammatory diseases.

TitleThe interplay between host immune cells and gut microbiota in chronic inflammatory diseases.
Publication TypeJournal Article
Year of Publication2017
AuthorsKim D, Zeng MY, Nunez G
JournalExp Mol Med
Volume49
Issue5
Paginatione339
Date Published2017 05 26
ISSN2092-6413
KeywordsAnimals, Arthritis, Rheumatoid, Asthma, Bacteria, Dysbiosis, Gastrointestinal Microbiome, Humans, Inflammation, Inflammatory Bowel Diseases, Intestinal Mucosa, Mice, Multiple Sclerosis
Abstract

Many benefits provided by the gut microbiota to the host rely on its intricate interactions with host cells. Perturbations of the gut microbiota, termed gut dysbiosis, affect the interplay between the gut microbiota and host cells, resulting in dysregulation of inflammation that contributes to the pathogenesis of chronic inflammatory diseases, including inflammatory bowel disease, multiple sclerosis, allergic asthma and rheumatoid arthritis. In this review, we provide an overview of how gut bacteria modulates host metabolic and immune functions, summarize studies that examined the roles of gut dysbiosis in chronic inflammatory diseases, and finally discuss measures to correct gut dysbiosis as potential therapeutics for chronic inflammatory diseases.

DOI10.1038/emm.2017.24
Custom 1

https://www.ncbi.nlm.nih.gov/pubmed/28546562?dopt=Abstract

Alternate JournalExp. Mol. Med.
PubMed ID28546562
PubMed Central IDPMC5454439
Grant ListR01 DK061707 / DK / NIDDK NIH HHS / United States
R01 DK091191 / DK / NIDDK NIH HHS / United States
T32 HL007517 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine Gale and Ira Drukier Institute for Children's Health 413 E. 69th Street New York, NY 10021